Brief: Equillium Announces Additional Patient Data At ASH 2021 Demonstrating Continued Positive And Durable Clinical Responses In Acute Graft-Versus-Host Disease Patients Treated With Itolizumab

Equillium

13/12/2021 13:14

Dec 13 (Reuters) - Equillium Inc  EQ.O :
    * EQUILLIUM ANNOUNCES ADDITIONAL PATIENT DATA AT ASH 2021
DEMONSTRATING CONTINUED POSITIVE AND DURABLE CLINICAL RESPONSES
IN ACUTE GRAFT-VERSUS-HOST DISEASE PATIENTS TREATED WITH
ITOLIZUMAB
    * EQUILLIUM - PIVOTAL STUDY IN AGVHD TO COMMENCE IN EARLY
2022

Source text for Eikon:  ID:nBw8Mm1Bja 
Further company coverage:  EQ.O 

 ((Reuters.Briefs@thomsonreuters.com;))